首頁 > 市場調查報告書 > 醫療設備

體外診斷泌尿科

市場調查報告書

商品編碼

1562494

尿液檢查市場規模、佔有率、成長分析、按產品類型、按應用、按地區 - 行業預測，2024-2031

Urinalysis Market Size, Share, Growth Analysis, By Product, By Test Type, By Application, By Region - Industry Forecast 2024-2031

出版日期: 2024年09月14日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球尿液檢查市場規模為39億美元，從2023年的42.8億美元成長到2031年的89.7億美元，預計複合年成長率為9.70%。

全球尿液檢查市場在醫療保健領域正在迅速擴大。尿液檢查或尿液檢查透過分析尿液樣本來診斷各種醫療狀況並監測整體健康狀況。這種診斷工具對於早期疾病檢測和管理至關重要，並已成為世界各地醫療保健機構的主要工具。技術和檢測方法的進步極大地提高了尿液檢查的準確性、效率和可靠性，增加了其在醫院、診所、診斷實驗室和居家醫療機構中的使用。推動尿液檢查市場成長的因素有很多。尿道感染、腎臟疾病和其他泌尿器官系統疾病的發生率上升是主要促進因素。此外，老年人口的不斷成長以及糖尿病、高血壓等慢性病的盛行率不斷增加，對常規尿液檢查的需求也隨之增加。此外，從傳統的手動測試到自動化照護現場(POC) 系統的轉變將提高測試的速度和便利性，使醫療保健專業人員能夠做出及時、明智的決策。市場競爭激烈，許多公司正在投資研發以推出創新產品和技術。主要企業正在尋求產品發布、合併、收購、聯盟和策略夥伴關係，以提高其市場佔有率和競爭力。總體而言，由於技術進步以及對早期疾病檢測和持續健康監測的需求不斷增加，全球尿液檢查市場預計將持續成長。

市場概況
消耗品
- 懷孕/不孕症治療套件
- 量油尺
- 試劑
- 一次性的
裝置
- 自動尿液分析儀
- 一體化尿液分析儀
- 尿液沉渣分析儀
- 流式細胞技術分析儀
- 顯微鏡分析儀
- 尿液生化分析儀
- 半自動尿液分析儀
- 照護現場尿液分析儀

尿液檢查市場：按測試類型

市場概況
妊娠及不孕症檢測
生物化學檢驗
- 臨床檢查
- POC測試
尿液檢查

尿液檢查市場：依應用分類

市場概況
疾病篩檢
- 尿道感染
- 腎臟疾病
- 糖尿病
- 肝臟疾病
- 其他
妊娠及不孕症檢測

尿液檢查市場：依最終用戶分類

市場概況
診斷實驗室
醫院/診所
居家照護環境
研究實驗室/研究機構

尿液檢查市場規模：按地區分類

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Siemens Healthineers AG（Germany）
F. Hoffmann-La Roche Ltd.（Switzerland）
Cardinal Health（US）
Danaher（US）
Abbott（US）
Sysmex Corporation（Japan）
Thermo Fisher Scientific Inc.（US）
QuidelOrtho Corporation（US）
Becton, Dickinson and Company（US）
Bio-Rad Laboratories, Inc.（US）
EKF Diagnostics Holdings PLC（UK）
Arkray, Inc.（Japan）
ACON Laboratories, Inc.（US）
77 Elektronika Kft.（Hungary）
URIT Medical Electronic Co., Ltd.（China）
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.（China）
Dirui Industrial Co., Ltd.（China）
BIOBASE Group（China）
Erba Mannheim（Germany）
Alphatec Scientific EIRL（Peru）
Teco Diagnostics（US）
Analyticon Biotechnologies GmbH（Germany）
Bioway Biological Technology Co., Ltd.（China）
High Technology, Inc.（US）
Agappe Diagnostics Ltd（India）
Toyobo Co., Ltd.（Japan）
DIALAB GmbH（Austria）
Quantimetrix（US）
Biocare Corporation（Taiwan）
Randox Laboratories Ltd.（UK）
PZ Cormay SA（Poland）
YD Diagnostics（South Korea）
Contec Medical Systems Co., Ltd.（China）
Biopanda Reagents Ltd.（UK）

簡介目錄

Product Code: SQMIG35A2632

Global Urinalysis Market size was valued at USD 3.9 billion in 2022 and is poised to grow from USD 4.28 billion in 2023 to USD 8.97 billion by 2031, growing at a CAGR of 9.70% during the forecast period (2024-2031).

The global urinalysis market is rapidly expanding within the healthcare sector. Urinalysis, or urine testing, involves analyzing urine samples to diagnose various medical conditions and monitor general health. This diagnostic tool is crucial for the early detection and management of diseases, making it a staple in healthcare settings worldwide. Advances in technology and testing methods have significantly enhanced the accuracy, efficiency, and reliability of urinalysis, leading to its increased use in hospitals, clinics, diagnostic labs, and homecare environments. Several factors are fueling the growth of the urinalysis market. The rising incidence of urinary tract infections, kidney diseases, and other urological disorders is a major driver. Additionally, the growing elderly population and the higher prevalence of chronic conditions like diabetes and hypertension have increased the demand for routine urine testing. The transition from traditional manual testing to automated and point-of-care urinalysis systems has also improved the speed and convenience of testing, allowing healthcare professionals to make timely and informed decisions. The market is highly competitive, with many companies investing in research and development to introduce innovative products and technologies. Key players are pursuing product launches, mergers, acquisitions, collaborations, and strategic partnerships to enhance their market presence and competitive edge. Overall, the global urinalysis market is poised for continued growth, driven by technological advancements and the increasing need for early disease detection and ongoing health monitoring.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Urinalysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Urinalysis Market Segmental Analysis

Global Urinalysis Market is segmented by Product, Test Type, Application, End User, and region. Based on Product, the market is segmented into Consumables, and Instruments. Based on Test Type, the market is segmented into Pregnancy & Fertility Tests, Biochemical Tests, and Sediment Urinalysis. Based on Application, the market is segmented into Disease Screening, and Pregnancy & Fertility Testing. Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics, Home Care Settings, and Research Laboratories & Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Urinalysis Market

A key driver of market growth is the increasing incidence of urinary tract infections (UTIs) in developing countries. This rising prevalence significantly impacts the market, as untreated UTIs can progress to affect the kidneys and lead to complications during pregnancy. The market's expansion is largely fueled by the potential severity of UTIs if left untreated. Complications such as kidney infections and adverse effects on pregnant women underscore the urgent need for effective diagnostic and treatment solutions, further propelling market development.

Restraints in the Global Urinalysis Market

The availability of reconditioned urine analyzers is expected to limit the market's growth during the forecast period. These devices, while cost-effective, may impact the demand for new, advanced analyzers, thereby constraining market expansion. Additionally, potential changes in regulatory environments could further challenge the growth of the urinalysis industry. Stricter regulations or altered oversight requirements might complicate market conditions and hinder future development.

Market Trends of the Global Urinalysis Market

The demand for point-of-care urinalysis testing is increasing, driven by its ability to deliver rapid, on-site diagnoses. This approach allows healthcare professionals to obtain immediate results, which supports quicker decision-making and enhances patient outcomes. Point-of-care testing is valued for its efficiency and convenience, offering real-time data that helps streamline clinical processes and improve overall patient care. The ability to conduct tests and receive results on the spot is becoming increasingly important in various healthcare settings.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Trade Analysis
Supply chain Analysis
Case study Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Urinalysis Market by Product

Market Overview
Consumables
- Pregnancy & Fertility Kits
- Dipsticks
- Reagents
- Disposables
Instruments
- Automated Urine Analyzers
- Integrated urine analyzers
- Sediment urine analyzers
- Flow cytometry analyzers
- Microscopy analyzers
- Biochemical urine analyzers
- Semi-automated Urine Analyzers
- Point-of-care Urine Analyzers

Urinalysis Market by Test Type

Market Overview
Pregnancy & Fertility Tests
Biochemical Tests
- Laboratory Tests
- POC Tests
Sediment Urinalysis

Urinalysis Market by Application

Market Overview
Disease Screening
- Urinary Tract Infections
- Kidney Diseases
- Diabetes
- Liver Diseases
- Others
Pregnancy & Fertility Testing

Urinalysis Market by End User

Market Overview
Diagnostic Laboratories
Hospitals & Clinics
Home Care Settings
Research Laboratories & Institutes

Urinalysis Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QuidelOrtho Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EKF Diagnostics Holdings PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arkray, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACON Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
77 Elektronika Kft. (Hungary)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
URIT Medical Electronic Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dirui Industrial Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIOBASE Group (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Erba Mannheim (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alphatec Scientific E.I.R.L. (Peru)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teco Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Analyticon Biotechnologies GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioway Biological Technology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
High Technology, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agappe Diagnostics Ltd (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Toyobo Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DIALAB GmbH (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quantimetrix (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocare Corporation (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Laboratories Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PZ Cormay S.A. (Poland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
YD Diagnostics (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Contec Medical Systems Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biopanda Reagents Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments